A study published in Neurology found that COVID-19 infection does not lead to immediate changes in symptom severity or disability in individuals with multiple sclerosis (MS). The study included 796 participants with COVID-19 and 1,336 uninfected participants, and found no significant difference in symptom trajectory or disability levels between the two groups before or after infection. The immediate impact of COVID-19 on MS symptoms was minimal. These findings provide reassurance about the impact of COVID-19 on individuals with MS and contribute to a better understanding of the consequences of infection in this population.
Source link
COVID-19 infection not linked to changes in MS symptom severity
